Shi‐Jun Xu
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Cancer-related gene regulation 2
-
- Immune Cell Function and Interaction 2
-
- Intracerebral and Subarachnoid Hemorrhage Research 2
-
- Renal cell carcinoma treatment 2
-
- Alzheimer's disease research and treatments 2
- Journals
- Journal of Molecular Biology (1 paper)International Journal of Molecular Sciences (2 papers)Cell Death and Differentiation (1 paper)
- Partner nations
- ChinaSouth KoreaEgypt
In The Last Decade
Shi‐Jun Xu
27 papers receiving 307 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 85
- Hepatology 40
- Molecular Biology 147
- Immunology 40
- Neurology 15
Countries citing papers authored by Shi‐Jun Xu
This map shows the geographic impact of Shi‐Jun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Jun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Jun Xu more than expected).
Fields of papers citing papers by Shi‐Jun Xu
This network shows the impact of papers produced by Shi‐Jun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Jun Xu. The network helps show where Shi‐Jun Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shi‐Jun Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 29 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 23 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 9 | |
| 15 | 2020 | 6 | |
| 16 | 2019 | 15 | |
| 17 | 2019 | 34 | |
| 18 | 2018 | 12 | |
| 19 | 2016 | 12 | |
| 20 | 2015 | 1 |
About Shi‐Jun Xu
Shi‐Jun Xu is a scholar working on Hepatology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 307 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (3 papers), Renal cell carcinoma treatment (2 papers), Intracerebral and Subarachnoid Hemorrhage Research (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer-related gene regulation (2 papers), Alzheimer's disease research and treatments (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (85 citations), Hepatology (40 citations) and Molecular Biology (147 citations). Shi‐Jun Xu has collaborated with scholars based in China, South Korea and Egypt. Frequent co-authors include Suhwan Chang, Hong-Tao Hu, Liang‐Hu Qu, Shu‐Juan Xie, Hui Zhou, Hui Xu, Yin Zhang, Jianhua Yang, Xiuqing Zhang and Weiqi Zhang. Their work appears in journals such as Journal of Molecular Biology, International Journal of Molecular Sciences and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.